High soluble CD30, CD25 and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides

Histopathology alone cannot predict outcome of patients with CD30+ primary cutaneous lymphoproliferative disorders (CD30CLPD) and early mycosis fungoides (MF). To test the hypothesis that serum cytokines/cytokine receptors provide prognostic information in these disorders, we measured soluble CD30 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadin, Marshall E., Pavlov, Igor, Delgado, Julio C., Vonderheid, Eric C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278552/
https://www.ncbi.nlm.nih.gov/pubmed/22071475
http://dx.doi.org/10.1038/jid.2011.351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278552/
https://www.ncbi.nlm.nih.gov/pubmed/22071475
http://dx.doi.org/10.1038/jid.2011.351

Ejemplares similares